GHSI Guardion Health Sciences
- 8.1400
- +0.1400+1.75%
Guardion Health Sciences News
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
Guardion Health Sciences Updates Executive Compensation Plans
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cash flow for the full fiscal year 2024.
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Shares of Biophytis S.A. (NASDAQ:BPTS) rose sharply in today's pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per s
Guardion Health Sciences Files to Sell 690,100 Shares of Common Stock
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Guardion Health Sciences 2023 Rev $12.2M >GHSI
Guardion Health Sciences 2023 Rev $12.2M >GHSI
Guardion Health Sciences 2023 EPS 12c >GHSI
Guardion Health Sciences 2023 EPS 12c >GHSI
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS,
11 Consumer Staples Stocks Moving In Thursday's Intraday Session
GainersBit Brother (NASDAQ:BETS) shares rose 55.4% to $2.77 during Thursday's regular session. The market value of their outstanding shares is at $1.7 million. Guardion Health Sciences (NASDAQ:GHSI) s
PRSO, AKRO and MIRA Among Pre-market Losers
Maxim Group Downgrades Guardion Health Sciences to Hold
Maxim Group analyst Anthony Vendetti downgrades Guardion Health Sciences (NASDAQ:GHSI) from Buy to Hold.
Guardion Health Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/02/2024 — Maxim Group Downgrades Buy → Hold 07/18/2022 -90.93% Ascendiant Capital → $0.75 Initiates Co
Investors Still Aren't Entirely Convinced By Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues Despite 53% Price Jump
Guardion Health Sciences, Inc. (NASDAQ:GHSI) shareholders would be excited to see that the share price has had a great month, posting a 53% gain and recovering from prior weakness.
Trending Stocks Today: Connexa Sports Technologies Shoots up 108.09%
January 31st - US stocks trending in regular trading hours.Gainers: $Connexa Sports Technologies(CNXA.US)$ soars 108.09% to $0.41 with a turnover of $117.82 million. $Minim(MINM.US)$ shoots up 60.53%
Why Guardion Health Sciences Stock Is Up Today
Guardion Health Sciences, Inc. (NASDAQ:GHSI) shares are trading higher Wednesday after the company announced it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, which owns the Viactiv brand and business.
Guardion Health Sciences Shares Resumed Trade Then Again Halted On Circuit Breaker
Guardion Health Sciences Shares Resumed Trade Then Again Halted On Circuit Breaker
Alphabet Earnings, Upcoming Fed Rate Decision Drive Mixed Premarket Action for US Equity Futures
US equity futures were mixed ahead of Wednesday's opening bell with futures of the technology-heavy Nasdaq Composite posting losses after the release of sector major Alphabet's (GOOG, GOOGL) Q4 earnin
Top Premarket Gainers
Guardion Health Sciences (GHSI) shares soared 70% Wednesday premarket after the company said it agreed to sell its Activ Nutritional subsidiary for $17.2 million. Revelation Biosciences (REVB) shares
Analysis
Price Target
No Data
